BIZENGRI vs HYCAMTIN

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate

Possible drug interaction. BIZENGRI and HYCAMTIN are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BIZENGRI	HYCAMTIN
Rating	New	68/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ZENOCUTUZUMAB-ZBCO	TOPOTECAN HYDROCHLORIDE
Manufacturer	Merus N.V.	Sandoz
Dosage forms	Injectable	Capsule, Injectable
Drug class	—	—
Boxed warning	Boxed warning	Boxed warning
Treats	Lung Neoplasms, Small Cell Lung Carcinoma	Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Ovarian Neoplasms

bizengri hycamtin

Rating

New

68/100

Pharmacy pays

—

Type

Active ingredient

ZENOCUTUZUMAB-ZBCO

TOPOTECAN HYDROCHLORIDE

Manufacturer

Merus N.V.

Sandoz

Dosage forms

Injectable

Capsule, Injectable

Drug class

—

Boxed warning

Treats

Lung Neoplasms, Small Cell Lung Carcinoma

Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Ovarian Neoplasms

Frequently asked questions

What is the difference between Bizengri and Hycamtin?

Bizengri contains Zenocutuzumab-Zbco, while Hycamtin contains Topotecan Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.